Concepedia
Statistics
Publications
31
Citations
916
H-Index
20
Active since
1995
Affiliations
Roche (Switzerland)(Current)
University of L'Aquila
Dalhousie University
European Brain Research Institute
Technical University of Munich
Matthias Nettekoven is an author at Roche (Switzerland) specializing in medicinal chemistry, pharmacology, and drug discovery.
Publications per year
1995–2024
Biochemical and behavioural characterization of EMPA, a novel high‐affinity, selective antagonist for the OX<sub>2</sub> receptor
P. Malherbe, Edilio Borroni, Luca Gobbi et al. · British Journal of Pharmacology · 2009 · 93 citations · Full text
Medicine, Neuroscience, Pharmacology +17
Ligand-Based Combinatorial Design of Selective Purinergic Receptor (A<sub>2A</sub>) Antagonists Using Self-Organizing Maps
Gisbert Schneider, Matthias Nettekoven · Journal of Combinatorial Chemistry · 2003 · 69 citations
Pharmacy, Medicinal Chemistry, Pharmacology +17
Lead Generation - Enhancing the Success of Drug Discovery by Investing in the Hit to Lead Process
Alexander Alanine, Matthias Nettekoven, Edward Roberts et al. · Combinatorial Chemistry & High Throughput Screening · 2003 · 58 citations
Pharmacy, Medicinal Chemistry, Drug Design +16
Novel Triazolopyrimidine‐Derived Cannabinoid Receptor 2 Agonists as Potential Treatment for Inflammatory Kidney Diseases
Matthias Nettekoven, Jean‐Michel Adam, Stefanie Bendels et al. · ChemMedChem · 2015 · 57 citations
Benzodioxoles: Novel Cannabinoid-1 Receptor Inverse Agonists for the Treatment of Obesity
Leo Alig, Jochem Alsenz, Mirjana Andjelković et al. · Journal of Medicinal Chemistry · 2008 · 42 citations · Full text
1–5 of 31